TY - JOUR
T1 - Metabolite signature in acute ischemic stroke thrombi
T2 - a systematic review
AU - Arul, Santhosh
AU - Ghozy, Sherief
AU - Mereuta, Oana Madalina
AU - Senol, Yigit Can
AU - Orscelik, Atakan
AU - Kobeissi, Hassan
AU - Gupta, Rishabh
AU - Brinjikji, Waleed
AU - Kallmes, David F.
AU - Kadirvel, Ramanathan
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/11
Y1 - 2023/11
N2 - Metabolites are reliable biomarkers for many diseases. However, their role in acute ischemic stroke (AIS) pathogenesis is not well understood. In this systematic review we aim to evaluate the current literature on the presence of metabolites in thrombi retrieved by mechanical thrombectomy from AIS patients. Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines, we searched OVID Medline, PubMed, OVID Embase, Scopus, and Web of Science until July 13, 2022. Metabolites lists were extracted, and pathway analysis was performed in MetaboAnalyst database. Four articles listing metabolites were included in this systematic review. D-Glucose, diacylglycerol, phytosphingosine, galabiosylceramide, glucosylceramide and 4-hydroxynonenal were reported to be associated with clots. Metabolomics data analysis showed that glycolysis, lactose, and sphingolipid metabolism pathways were enriched. In conclusion, results of the present study show that the thrombi niche has a glycolytic phenotype. Future studies should work to better understand the metabolic properties of AIS thrombi.
AB - Metabolites are reliable biomarkers for many diseases. However, their role in acute ischemic stroke (AIS) pathogenesis is not well understood. In this systematic review we aim to evaluate the current literature on the presence of metabolites in thrombi retrieved by mechanical thrombectomy from AIS patients. Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines, we searched OVID Medline, PubMed, OVID Embase, Scopus, and Web of Science until July 13, 2022. Metabolites lists were extracted, and pathway analysis was performed in MetaboAnalyst database. Four articles listing metabolites were included in this systematic review. D-Glucose, diacylglycerol, phytosphingosine, galabiosylceramide, glucosylceramide and 4-hydroxynonenal were reported to be associated with clots. Metabolomics data analysis showed that glycolysis, lactose, and sphingolipid metabolism pathways were enriched. In conclusion, results of the present study show that the thrombi niche has a glycolytic phenotype. Future studies should work to better understand the metabolic properties of AIS thrombi.
KW - Metabolite
KW - Signature
KW - Stroke
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85168107027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85168107027&partnerID=8YFLogxK
U2 - 10.1007/s11239-023-02869-9
DO - 10.1007/s11239-023-02869-9
M3 - Review article
C2 - 37580625
AN - SCOPUS:85168107027
SN - 0929-5305
VL - 56
SP - 594
EP - 602
JO - Journal of Thrombosis and Thrombolysis
JF - Journal of Thrombosis and Thrombolysis
IS - 4
ER -